A OPEN STUDY OF METRONOMIC ORAL VINORELBINE IN COMBINATION WITH AROMATASE INHIBITORS FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR POSITIVE,HER2-NEGATIVE, ADVANCED BREAST CANCER WHO RECEIVED NO PRIOR THERAPY FOR ADVANCED DISEASE: